Quarterly ResultMay 6, 2026, 06:36 AM
Bruker Q1 Revenue $823.4M, GAAP EPS $0.02; Reaffirms FY26 Guidance
AI Summary
Bruker Corporation announced its first quarter 2026 financial results, reporting revenues of $823.4 million, a 2.7% increase year-over-year, though organic revenue decreased by 4.4%. GAAP diluted EPS fell to $0.02 from $0.11 in Q1 2025, and non-GAAP diluted EPS was $0.31, down from $0.47. Despite the Q1 pressures, the company saw healthy bookings for its Bruker Scientific Instruments (BSI) segment, with a book-to-bill ratio above 1.0x. Bruker reconfirmed its full-year 2026 guidance, expecting a return to organic revenue growth in Q2 and double-digit EPS growth for the full fiscal year.
Key Highlights
- Q1 2026 revenues were $823.4 million, up 2.7% year-over-year, but down 4.4% organically.
- Q1 2026 GAAP diluted EPS was $0.02, down from $0.11 in Q1 2025.
- Q1 2026 non-GAAP diluted EPS was $0.31, down from $0.47 in Q1 2025.
- Bruker Scientific Instruments (BSI) bookings grew high-single digits % organically year-over-year.
- BSI book-to-bill ratio was above 1.0x for the third consecutive quarter.
- FY2026 revenue guidance reconfirmed at $3.57 to $3.60 billion, up 4% to 5% yoy.
- FY2026 non-GAAP EPS guidance reconfirmed at $2.10 to $2.15, up 15% to 17% yoy.
- Q1 2026 BSI revenues were $759.8 million, up 2.1% yoy, with organic revenue decreasing 5.0%.